PRAX 8-K: SEC filing
Filed with the SEC on · accession 0001689548-26-000091
PRAX filed a 8-K (current report) with the SEC on Nov 12, 2026. Praxis Precision Medicines hosted an Investor Day on November 12, 2026, presenting commercial strategy and launch plans for relutrigine in SCN2A/SCN8A DEEs and ulixacaltamide in essential tremor, along with pipeline updates including new programs in movement disorders, pain, and epilepsy.
Summary of the filing
Praxis Precision Medicines hosted an Investor Day on November 12, 2026, presenting commercial strategy and launch plans for relutrigine in SCN2A/SCN8A DEEs and ulixacaltamide in essential tremor, along with pipeline updates including new programs in movement disorders, pain, and epilepsy. The company shared updated clinical data, prevalence estimates, and development timelines for multiple product candidates.
Key details
✦ Ask GOAX AI about this filing — what it means for PRAX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PRAX?
Click hereFrequently asked questions
What did PRAX file with the SEC on Nov 12, 2026?
PRAX filed a 8-K (SEC filing). Praxis Precision Medicines hosted an Investor Day on November 12, 2026, presenting commercial strategy and launch plans for relutrigine in SCN2A/SCN8A DEEs and ulixacaltamide in essential tremor, along with pipeline updates including new programs in movement disorders, pain, and epilepsy. The company shared updated clinical data, prevalence estimates, and development timelines for multiple product candidates.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other PRAX SEC filings
- 10-Q · SEC filingNov 9, 2026
- 8-K · SEC filingNov 9, 2026
- SCHEDULE 13G/A · SEC filingNov 5, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · SEC filingAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · Material agreementJul 7, 2026
- 8-K · SEC filingJul 2, 2026
- 8-K · Regulatory actionJun 29, 2026
- 8-K · Fda approvalJun 22, 2026
Get alerts when PRAX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days